References: Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Letter]

Views

CrossRef citations to date

Altmetric

References

Takahashi PY, Ryu E, Bielinski SJ, et al. No association between pharmacogenomics variants and hospital and emergency department utilization: a Mayo Clinic Biobank Retrospective Study. Pharmgenomics Pers Med. 2021;14:229–237. doi:10.2147/PGPM.S281645
Web of Science ®Google Scholar
Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011;89(3):464–467. doi:10.1038/clpt.2010.279
PubMed Web of Science ®Google Scholar
Roman YM. Race and precision medicine: is it time for an upgrade? Pharmacogenomics J. 2019;19(1):1–4. doi:10.1038/s41397-018-0046-0
Web of Science ®Google Scholar
Shah SN, Gammal RS, Amato MG, et al. Clinical utility of pharmacogenomic data collected by a health-system Biobank to predict and prevent adverse drug events. Drug Saf. 2021. doi:10.1007/s40264-021-01050-6
Web of Science ®Google Scholar
Okoli GN, Sanders RD, Myles P. Demystifying propensity scores. Br J Anaesth. 2014;112(1):13–15. doi:10.1093/bja/aet290
PubMed Web of Science ®Google Scholar